WOVEN-PLANET-HOLDINGS
26.4.2022 06:32:12 CEST | Business Wire | Press release
Nissin Food Products Co., Ltd. (Nissin Foods) and Toyota Motor Corporation (Toyota) have initiated an agreement to jointly foster human well-being through healthy eating. This proposed plan will explore using Nissin’s innovative food offering, based on the latest molecular nutritional science, to provide personalized, delicious, and healthy “Complete Nutrition Meals” for Woven City. Woven City is being developed in Susono City, Shizuoka Prefecture on behalf of Toyota by Woven Planet, Inc. (Woven Planet), a Toyota subsidiary.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220425005380/en/
Specifically, the following initiatives will be considered.
(1) A joint demonstration on expanding food choices for Woven City and improve residents’ health through the provision of "Complete Nutrition Meals”
(2) Connect data to provide "Complete Nutrition Meals" optimization based on each individual’s needs
Through Woven City, Toyota is aiming to transform itself into a mobility company and will conduct many demonstrations with various partners. With Woven City, Toyota is taking on the challenge of pursuing well-being for all and expanding the very definition of "mobility" to make it more human-centered. The word "mobility" includes not only getting from point A to point B, but also "moving" people's hearts.
Under the slogan "Beyond Instant Foods," Nissin Foods is taking on the challenge of creating a new food culture that goes beyond the value of instant foods. As one of these efforts, Nissin Foods has been researching "Complete Nutrition Meals" that provide all the necessary nutrients with controlled calories, salt, sugar, and fat, while maintaining the appearance and taste of the food. Applying the technology they have developed for instant noodles and other products, Nissin Foods is making various efforts to realize food for the future by utilizing proprietary and cutting-edge food production technology.
Nissin Foods' goal of "Beyond Instant Foods" and Toyota Woven City's goal of "broadening the scope of mobility" are essentially the same, even if the industries involved are different. These aspirations of both companies are in line with each other, and have led to this basic agreement. The two companies will work together to realize well-being through food by offering Nissin Foods' "Complete Nutrition Meals" in Woven City, aiming for delicious and healthy products that are optimized for each individual’s needs.
“We strongly share Toyota's vision of ‘well-being for all’ and are very pleased to be a part of Woven City. This initiative is the first step toward realizing a ‘new diet’ that allows people to enjoy a ‘Complete Nutrition Meal’ optimized for each individual anytime, anywhere. We will continue to work on improving well-being through food by conducting medium to long-term demonstrations in Woven City based on the themes of ‘food and nutrition’ and ‘the correlation between food and the extension of healthy life expectancy.’ We will continue to take on further challenges to realize a world where people can enjoy whatever they want, whenever they want, and as much as they want, as never seen before, under the slogan "#Japan as a nation on the cutting edge of preventive medicine.”
Noritaka Ando, Executive Vice President & Representative Director, Chief Operating Officer of NISSIN FOODS HOLDINGS CO., LTD. and President & Representative Director of Nissin Food Products Co., Ltd.
“We are excited to partner with Nissin Foods, Japan’s leading food production company which is on an ongoing mission to create a new food culture beginning with the development of the world's first instant noodles. Through Woven City, Toyota strives to achieve well-being for all by conducting trials that will expand the meaning and value of ‘mobility’ and create healthy and satisfying eating experiences that ‘move’ people's hearts. While health requirements and eating preferences differ across individuals, within the living laboratory of Woven City, we will learn more about how custom diets inspire healthier lifestyles and greater happiness.
The problem of food waste and lack of access to affordable, healthy food is a global human rights issue. Toyota and Woven Planet believe that Toyota Production System principles that Toyota developed and implemented in Just-In-Time delivery of parts and supplies for manufacturing operations, have the potential to improve food supply chain operations, optimize freshness, and reduce food waste, if applied to food production and delivery.”
James Kuffner, Board of Directors Member and Chief Digital Officer of Toyota Motor Corporation and CEO of Woven Planet, Inc.
About Nissin Foods:
Nissin Food Products Co., Ltd. (Nissin Foods) history begins in 1958, from the invention of the world's first instant noodles, Chicken Ramen. Since then, Nissin Foods has continued to create new food cultures through the development of products such as the first cup-type instant noodles, Cup Noodles, and the world's first space food ramen, Space Ram. The instant noodles market has since been growing globally, now reaching an annual consumption of 100 billion servings. As a pioneer in creating new food cultures, Nissin Foods will continue to lead the global food scene through creativity and technology, under the slogan: "Beyond Instant Foods".
For more information, please visit https://www.nissin.com/en_jp/
About Toyota Motor Corporation
Toyota Motor Corporation (Toyota) (NYSE: TM) is the global mobility company that introduced the Prius hybrid-electric car in 1997 and the first mass-produced fuel cell sedan, Mirai, in 2014. Headquartered in Toyota City, Japan, Toyota has been making cars since 1937. Today, Toyota proudly employs 370,000 employees in communities around the world. Together, they build around 10 million vehicles per year in 28 countries and regions, from mainstream cars and premium vehicles to mini-vehicles and commercial trucks, and sell them in more than 170 countries and regions under the brands Toyota, Lexus, Daihatsu and Hino.
For more information, please visit https://global.toyota/en
About Woven Planet
Woven Planet is building the safest mobility in the world. A subsidiary of Toyota, Woven Planet innovates and invests in new technologies, software, and business models that transform how we live, work and move. With a focus on automated driving, smart cities, robotics and more, Woven Planet builds on Toyota's legacy of trust to deliver secure, connected, reliable, and sustainable mobility solutions for all.
Learn more at https://www.woven-planet.global/en
View source version on businesswire.com: https://www.businesswire.com/news/home/20220425005380/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom